Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma

Detalles Bibliográficos
Autores principales: Ma, Dongshen, Zhang, Qin, Duan, Qianqian, Tan, Yuan, Sun, Tingting, Qi, Chuang, Qin, Yong, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004013/
https://www.ncbi.nlm.nih.gov/pubmed/35410220
http://dx.doi.org/10.1186/s12967-022-03324-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004013/
https://www.ncbi.nlm.nih.gov/pubmed/35410220
http://dx.doi.org/10.1186/s12967-022-03324-8

Ejemplares similares